M
Michael Oelgeschläger
Researcher at Federal Institute for Risk Assessment
Publications - 22
Citations - 441
Michael Oelgeschläger is an academic researcher from Federal Institute for Risk Assessment. The author has contributed to research in topics: Embryonic stem cell & Cancer. The author has an hindex of 10, co-authored 22 publications receiving 342 citations.
Papers
More filters
Journal ArticleDOI
Editor's Highlight: Identification and Characterization of Teratogenic Chemicals Using Embryonic Stem Cells Isolated From a Wnt/β-Catenin-Reporter Transgenic Mouse Line.
TL;DR: The use of a Wnt/β-Catenin-reporter ESC line isolated from a previously described mouse line that carries the LacZ reporter gene under the control of a β- Catenin responsive promoter is described.
Journal ArticleDOI
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research.
Christopher Weidner,Matthias Steinfath,Elisa Wistorf,Michael Oelgeschläger,Marlon R. Schneider,Gilbert Schönfelder +5 more
TL;DR: A standardized protocol for the use of GSEA to distinguish between appropriate and inappropriate animal models for translational research is developed, thus avoiding unnecessary animal experiments and misleading translational studies.
Book ChapterDOI
The Advent of the Golden Era of Animal Alternatives
Daniel Butzke,Barbara Grune,Josephine Kugler,Michael Oelgeschläger,Andrea Seiler,Dana Sittner,Manfred Liebsch,Andreas Luch +7 more
TL;DR: The first years of the 21 st century have seen an unparalleled progress in biomedical sciences, and several new approaches, e.g., stem cell-based, diseases-in- a-dish and organs-on-a-chip and lab-on a-chip technologies have revitalized the domain of alternatives to animal experimentation.
Journal ArticleDOI
A quantitative medium-throughput assay to measure Caenorhabditis elegans development and reproduction.
Paul Wittkowski,Norman Violet,Michael Oelgeschläger,Gilbert Schönfelder,Gilbert Schönfelder,Silvia Vogl +5 more
TL;DR: Wittkowski et al. as mentioned in this paper presented a protocol for a 96 h, medium-throughput assay, assessing growth and offspring count quantitatively within an automated framework using open-source software.
Journal ArticleDOI
Transgenic Mouse Models Transferred into the Test Tube: New Perspectives for Developmental Toxicity Testing In Vitro?
TL;DR: This work proposes combining transgenic mouse models harboring easily detectable reporter genes under the control of evolutionarily conserved signaling cascades with existing alternative toxicological testing strategies to enable the plausibility of in vitro data to be verified in light of in vivo data and facilitate regulatory acceptance ofIn vitro test methods.